Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Goodwill & Intangibles (2016 - 2025)

Amicus Therapeutics filings provide 13 years of Goodwill & Intangibles readings, the most recent being $211.7 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 1.53% to $211.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $211.7 million, a 1.53% decrease, with the full-year FY2025 number at $211.7 million, down 1.53% from a year prior.
  • Goodwill & Intangibles hit $211.7 million in Q4 2025 for Amicus Therapeutics, roughly flat from $212.5 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $220.8 million in Q4 2021 to a low of $211.7 million in Q4 2025.
  • Median Goodwill & Intangibles over the past 5 years was $219.5 million (2023), compared with a mean of $218.1 million.
  • Biggest five-year swings in Goodwill & Intangibles: changed 0.0% in 2021 and later decreased 1.53% in 2025.
  • Amicus Therapeutics' Goodwill & Intangibles stood at $220.8 million in 2021, then dropped by 0.0% to $220.8 million in 2022, then decreased by 1.14% to $218.3 million in 2023, then decreased by 1.51% to $215.0 million in 2024, then fell by 1.53% to $211.7 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $211.7 million (Q4 2025), $212.5 million (Q3 2025), and $213.4 million (Q2 2025) per Business Quant data.